LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 1 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 2.66 | 84.90 | 572 | 285 | 2.0018 | 1.9729 | MN20160318_Q02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 2.66 | 84.90 | 672 | 285 | 2.3518 | 2.2595 | MN20160318_Q02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 4.36 | 84.90 | 2 | 322 | 0.0062 | -0.8572 | MN20160318_Q02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 4.36 | 84.90 | 605 | 322 | 1.8756 | 1.7724 | MN20160318_Q02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 4.36 | 84.90 | 747 | 322 | 2.3158 | 2.0931 | MN20160318_Q02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 6.06 | 84.90 | 670 | 365 | 1.8333 | 1.6671 | MN20160318_Q02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 6.06 | 84.90 | 764 | 365 | 2.0906 | 1.8386 | MN20160318_Q02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 7.77 | 84.90 | 2 | 411 | 0.0049 | -0.8073 | MN20160318_Q02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 7.77 | 84.90 | 719 | 411 | 1.7484 | 1.5564 | MN20160318_Q02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 7.77 | 84.90 | 840 | 411 | 2.0426 | 1.7372 | MN20160318_Q02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 9.47 | 84.90 | 735 | 447 | 1.6427 | 1.4600 | MN20160318_Q02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 9.47 | 84.90 | 905 | 447 | 2.0227 | 1.6829 | MN20160318_Q02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 11.18 | 84.90 | 2 | 492 | 0.0041 | -0.7719 | MN20160318_Q02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 11.18 | 84.90 | 798 | 492 | 1.6208 | 1.4195 | MN20160318_Q02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 11.18 | 84.90 | 2 | 492 | 0.0041 | -0.7719 | MN20160318_Q02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 11.18 | 84.90 | 961 | 492 | 1.9518 | 1.6035 | MN20160318_Q02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 12.88 | 84.90 | 2 | 531 | 0.0038 | -0.7576 | MN20160318_Q02 | E14 |